Andrew Jackson

Andrew Jackson's AcademicInfluence.com Rankings

Andrew Jackson

Medical

#3718

World Rank

#4222

Historical Rank

Oncology

#265

World Rank

#273

Historical Rank

medical Degrees

Andrew Jackson

Engineering

#8336

World Rank

#9865

Historical Rank

Biomedical Engineering

#850

World Rank

#863

Historical Rank

Applied Physics

#3009

World Rank

#3074

Historical Rank

engineering Degrees

Download Badge

Medical
Engineering

Andrew Jackson's Degrees

PhD Biomedical Engineering Stanford University
Masters Biomedical Engineering Stanford University

Why Is Andrew Jackson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Andrew Jackson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Use of normal tissue complication probability models in the clinic. (2010) (1415)
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. (2010) (925)
Radiation dose-volume effects in the lung. (2010) (890)
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. (2008) (703)
Radiation dose-volume effects in radiation-induced rectal injury. (2010) (641)
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. (2000) (565)
Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. (2001) (356)
Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. (2000) (328)
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. (2002) (295)
Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. (1995) (249)
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. (2004) (245)
The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. (2012) (232)
Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. (2010) (224)
Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. (1993) (222)
Radiation therapy and hearing loss. (2010) (214)
The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. (2010) (200)
Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma (2005) (188)
Involved-field radiation therapy for inoperable non small-cell lung cancer. (2007) (156)
Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. (2004) (155)
Intensity-modulated radiotherapy. (2002) (154)
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma (2005) (144)
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. (2008) (138)
Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. (2016) (130)
Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. (1993) (123)
Optimization of intensity-modulated 3D conformal treatment plans based on biological indices. (1995) (123)
The potential and limitations of the inverse radiotherapy technique. (1994) (120)
Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer. (2014) (119)
Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree. (2016) (116)
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. (2010) (108)
Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. (2011) (107)
Local Control After Stereotactic Body Radiation Therapy for Liver Tumors. (2018) (107)
Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. (2012) (106)
Radiation DoseVolume Effects in the Lung (2010) (96)
Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy. (2014) (95)
Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. (2002) (94)
Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data. (2001) (88)
Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases. (2008) (87)
Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. (2003) (87)
Spinal cord dose tolerance to stereotactic body radiotherapy. (2019) (72)
Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. (2006) (71)
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. (2002) (65)
A nomogram to predict loco-regional control after re-irradiation for head and neck cancer. (2014) (65)
Dosimetric effect of respiratory motion in external beam radiotherapy of the lung. (2004) (62)
Radiation Dose-Volume Effects for Liver SBRT. (2018) (56)
Evaluating inter-campus plan consistency using a knowledge based planning model. (2016) (51)
Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer. (2008) (50)
Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors. (2014) (50)
High-Dose Radiotherapy for the Treatment of Inoperable Non–Small Cell Lung Cancer (2007) (49)
Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients. (2019) (48)
Partial irradiation of the rectum. (2001) (45)
Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. (2015) (44)
Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. (2009) (43)
Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: implications for defining postradiotherapy urinary toxicity. (2013) (42)
Can current models explain the lack of liver complications in Y-90 microsphere therapy? (1999) (42)
The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols. (2006) (42)
Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. (2000) (40)
Modeling pancreatic tumor motion using 4-dimensional computed tomography and surrogate markers. (2015) (40)
Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma? (2018) (40)
(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy. (2008) (37)
High-tech will improve radiotherapy of NSCLC: a hypothesis waiting to be validated. (2004) (37)
A Systematic Post-QUANTEC Review of Tolerance Doses for Late Toxicity After Prostate Cancer Radiation Therapy. (2018) (36)
A new method of incorporating systematic uncertainties in intensity-modulated radiotherapy optimization. (2005) (33)
High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview. (2021) (32)
Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters (2013) (31)
Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases. (2020) (30)
Reduced-order parameter optimization for simplifying prostate IMRT planning (2007) (30)
A Detailed Dosimetric Analysis of Spinal Cord Tolerance in High-Dose Spine Radiosurgery. (2017) (29)
Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models. (2014) (29)
Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response. (2020) (28)
Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer. (2019) (26)
Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer (2003) (25)
Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models. (2019) (24)
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction (2016) (22)
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab (2020) (22)
Local and Global Function Model of the Liver. (2016) (21)
Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer. (2019) (21)
The Use of Normal Tissue Complication Probability (NTCP) Models in the Clinic (2014) (21)
Perspectives of multidimensional conformal radiation treatment. (1993) (20)
The potential and limitations of the inverse radiotherapy technique (1995) (20)
Analysis of Toxic Effects With Antiangiogenic Agents Plus Stereotactic Body Radiation in Ultracentral Lung Tumors (2019) (17)
Reduced-order constrained optimization in IMRT planning (2008) (17)
Impact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain. (2015) (16)
Library of deep-learning image segmentation and outcomes model-implementations. (2020) (15)
Local Control Following Stereotactic Body Radiotherapy for Liver Tumors: A Preliminary Report of the AAPM Working Group for SBRT (2014) (15)
1008 Correlation of DVH and treatment planning variables with late rectal bleeding after 3D-CRT of prostate cancer: What is the best way to define the rectal length and volume? (1999) (15)
Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In regard to Brown et al. (2014) (15)
Quantifying cell migration distance as a contributing factor to the development of rectal toxicity after prostate radiotherapy. (2014) (15)
Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards. (2021) (14)
Principal component, Varimax rotation and cost analysis of volume effects in rectal bleeding in patients treated with 3D-CRT for prostate cancer (2006) (14)
Optimization of 3-D conformal radiation treatment plans. (1996) (14)
Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer. (2020) (14)
Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols. (2013) (13)
Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy. (2018) (13)
Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients with Non-Small Cell Lung Cancer Undergoing Post-Operative Radiation Therapy. (2020) (13)
Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma. (2017) (13)
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): Clinical Use (2009) (13)
Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors. (2020) (12)
Learning the relationship between patient geometry and beam intensity in breast intensity-modulated radiotherapy (2006) (12)
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC (2021) (11)
Are unsatisfactory outcomes after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer due to treatment-related immunosuppression? (2020) (10)
Comments on "Sampling techniques for the evaluation of treatment plans" [Med. Phys. 20, 151-161 (1993)]. (1993) (10)
Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control (2018) (9)
A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning (2017) (9)
A Primer on Dose-Response Data Modeling in Radiation Therapy. (2020) (8)
Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Assess Normal Tissue Radiation Dose-Volume-Response Relationships for Children With Cancer. (2021) (8)
Rectal bleeding after conformal radiotherapy of prostate cancer and dose volume histograms (1998) (8)
Modeling Dose Response for Late Dysphagia in Patients With Head and Neck Cancer in the Modern Era of Definitive Chemoradiation. (2017) (8)
Reduced order constrained optimization (ROCO): clinical application to lung IMRT. (2010) (7)
Spatial and Anatomical Indicators of Rectal Toxicity in IMRT of Prostate Cancer (2007) (7)
Ototoxicity following combined modality therapy for nasopharyngeal carcinoma (2000) (7)
Reduced order constrained optimization (ROCO): Clinical application to lung IMRT (2011) (6)
A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning. (2017) (4)
46 Improved conformality and reduced toxicity with high-dose intensity modulated radiation therapy (IMRT) for patients with prostate cancer (1999) (4)
Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review. (2022) (4)
Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 cm (2012) (4)
A theoretical investigation of adequate range uncertainty margins in proton treatment planning to preserve tumor control probability (2019) (4)
The Lyman and a current parallel model: are they equivalent in predicting radiation induced lung toxicity (2000) (4)
Brachial Plexopathy After High-Dose Stereotactic Body Radiation Therapy (SBRT) (2013) (3)
The Relative Biological Effectiveness of Carbon Ion Radiation Therapy for Early Stage Lung Cancer. (2020) (3)
Succesful Implementation of Atlas Segmentation for Cardiac Substructures (2017) (3)
Correlation of Respiratory Motion of Pancreatic Tumors with Biliary Stent or Intra-Tumoral Fiducials: Consequences for ITV and Respiratory Gating (2011) (2)
SP-0112: Dose to cardiac substructures predicts survival in non-small cell lung cancer chemo-radiotherapy (2018) (2)
Reduced-order constrained optimization (ROCO): clinical application to head-and-neck IMRT. (2013) (2)
Analysis of geometric and dosimetric factors that correlate with late rectal bleeding after conformal radiotherapy of prostate cancer (1998) (2)
Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer (2021) (2)
Abstract226: EUD and Dose-Volume Based Atlases of Complication Incidence: A Proposal for New Standards in Reporting Results of Treatment Protocols (2006) (2)
The Lessons of QUANTEC (Quantitative Analysis of Normal Tissue Effects in the Clinic): Recommendations for Reporting and Gathering Data on Dose-Volume Dependencies of Treatment Outcome (2009) (2)
Dose-Volume and Clinical Correlates of Radiation Pneumonitis in Non-Small Cell Lung Cancer Patients Treated with Post-Operative Radiation Therapy (2018) (1)
Correlation of the Dose Delivered to the Nausea Center With Acute Onset of Nausea and Vomiting in Oropharynx Cancer Patients Treated With Chemoradiation (2012) (1)
Modeling the Risk of Hearing Loss from Radiotherapy in Childhood Cancer Survivors: Initial Results from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) Hearing Loss Task Force (2019) (1)
Library of model implementations for sharing deep-learning image segmentation and outcomes models (2019) (1)
WE‐E‐BRA‐03: Therapy Symposium: A Clinician's View of Quantec (2011) (1)
Modeling Regional Sensitivity of Radiation Pneumonitis using Multi-institutional EUD Atlases from Phase I Dose Escalation Protocols for Non-small Cell Lung Cancer (2010) (1)
SU-E-J-64: Landmark and ROI-Enhancement-Assisted Inter-Patient Deformable Registration of 3D Bladder CT Images. (2013) (1)
MO-G-BRF-09: Local and Global Function Probability of the Liver. (2014) (1)
Novel quantitative generalized total effective entrapment (gTEE) metric for enhanced clinical outcome prediction: application to PET/CT imaging of pancreatic cancer (2015) (1)
Local Control and Toxicity in a Large Cohort of Central Lung Tumors Treated With Stereotactic Body Radiotherapy (2014) (1)
Dose Response for Veno-Occlusive Disease After Whole-Liver Radiation Therapy: A Preliminary Report From the Pediatric Normal Tissue Effects in the Clinic (PENTEC) Group (2018) (1)
The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases. (2022) (1)
Lack of validation of lymphopenia as a prognostic factor in esophageal cancer chemoradiation (2018) (1)
Risk Factors Associated with Pulmonary Toxicities from Multiple Courses of Stereotactic Body Radiation Therapy (SBRT) for Synchronous or Metachronous Primary Lung Tumors or Lung Metastases (2020) (1)
Dosimetric consequence of three setup correction schemes for external-beam radiotherapy of prostate cancer (2002) (1)
Treatment planning and outcomes effects of reducing the preferred mean esophagus dose for conventionally fractionated non‐small cell lung cancer radiotherapy (2021) (1)
OC-0097: Radiation dose-volume effects for liver SBRT (2016) (1)
The relationship between parotid gland-PTV overlap and the ability to achieve dosimetric sparing of the parotid using intensity modulated radiation therapy (2004) (1)
Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design (2020) (1)
Indocyanine Green for Individualized Assessment of Functional Liver Reserve in Patients Undergoing Liver Radiation Therapy (2013) (1)
Pitfalls in deducing radiobiological parameters for tumors from clinical data: a study of biopsy outcome after three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer☆ (2000) (1)
136 : Evaluation of Doses on a 2D Map of the Rectal Wall for Patients Treated With IMRT for Prostate Cancer (2006) (1)
Challenges of re-irradiation: A call to arms for physicists - and radiotherapy vendors. (2023) (1)
Dose Response of Dysphagia in Head and Neck Cancer Patients (2011) (1)
P05.10 Risk Factors Associated with Pulmonary Toxicities from Multiple Courses of Lung Stereotactic Body Radiation Therapy (SBRT) (2021) (0)
Radiotherapy outcomes modeling in the big data era (2019) (0)
External Validation of Pulmonary Toxicity Risk Model for Ultracentral Lung Tumors. (2021) (0)
A Comparison of Two-Dimensional and Conformal Radiotherapy for Post-Operative Treatment of Non-Small Cell Lung Cancer (NSCLC) (2005) (0)
External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors (2022) (0)
In Reply to Schultheiss. (2021) (0)
Dosimetric Predictors of Radiation Pneumonitis After Hemithoracic Pleural Intensity Modulated Radiation Treatment (2016) (0)
A Novel Method to Quantify Cell Migration Distance and Determine Its Contribution to the Development of Rectal Toxicity After Prostate Radiation Therapy (2013) (0)
TU‐C‐224A‐04: Simplifying Parameter Adjustment for Prostate IMRT Planning Using Sensitivity Analysis (2006) (0)
Dose Response of Dysphagia in Oropharynx Cancer Patients (2010) (0)
SU‐FF‐T‐421: Acceleration of Photon Monte Carlo Dose Calculation Using Multi‐Resolution Voxel Transport Geometry (2009) (0)
RELATING THREE DIMENSIONAL DOSE/VOLUME DATA TO CLINICAL OUTCOMES: AN OVERVIEW OF THE QUANTEC EFFORT (2011) (0)
Using logical combinations of structures as a utility for inverse planning (1998) (0)
A comparison of treatment plans for lung patients generated using different objectives during optimization (2004) (0)
Mean Dose to Larynx as a Predictor of Late Dysphagia after Definitive Intensity Modulated Radiotherapy (IMRT) for Squamous Cell Carcinoma (SCC) of the Head and Neck (2011) (0)
Subjective Hearing Loss (SHL) after Chemoradiation for Nasopharyngeal and Oropharyngeal Cancer Patients (2011) (0)
Heart Dosimetry is Correlated with Risk of Radiation Pneumonitis after Lung-Sparing Hemithoracic Pleural IMRT for Malignant Pleural Mesothelioma (2017) (0)
P05.01 Personalized Optimization of TCP Using NTCP Based Constraints for Ultracentral Lung Tumors (2021) (0)
MA02.06 Dose-Volume Factors Predicting Airway Stenosis After SBRT for Ultra-Central Lung Tumors (2019) (0)
2262 : Correlation of Planning Scan Anatomy and PSA Relapse in Prone Prostate Cancer Patients (2006) (0)
Brain and Brainstem Necrosis after Re-Irradiation for Recurrent Childhood Central Nervous System (CNS) Tumors: A Report from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) Task Force (2022) (0)
288 a Response-Driven Ntcp Model Based Upon Global and Local Liver Function Measures (2012) (0)
Modeling Volume Effects for Pneumonitis in Multi-institutional Non-small Cell Lung Cancer (NSCLC) Data using gEUD Atlases of Complication Incidence (2008) (0)
Dose-volume Factors Predicting Radiation Pneumonitis after SBRT for Ultra-central Lung Tumors (2019) (0)
PO-0997: Towards personalized dose-escalation in non-small cell lung cancer: Validation of published models (2018) (0)
Dose-Volume Response Analysis of Chest Wall Pain following SBRT using Proportional Hazards Models (2011) (0)
Dosimetric and Clinical Correlates of Absolute Neutrophil Count and Overall Survival After Concurrent Chemoradiation for Esophageal Cancer (2019) (0)
Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancer (2023) (0)
Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control (2018) (0)
PO-BPC-Exhibit Hall-02 Intermediate Dose Calculation During Optimization Improves Plan Quality for Lung IMRT and SBRT - (2015) (0)
SU‐FF‐T‐101: Volumetric Modulated Arc Therapy for the Treatment of Paraspinal Lesions (2009) (0)
PD-0785 Personalized fractionation of ultracentral lung tumors using modeled outcomes from treated patients (2021) (0)
TH‐AB‐304‐01: Dose‐Volume Relations for Late Rectal Bleeding in 1001 Patients From Five Prostate Cancer Cohorts (2015) (0)
In Reply to Klement et al. (2019) (0)
PD-0135: The impact of radiation therapy technology and treatment protocol on high-risk prostate cancer outcome (2013) (0)
Chemotherapy and Intensity Modulated Radiation Therapy (IMRT) for Stage III Non-small Cell Lung Cancer (NSCLC) (2008) (0)
Is It Safe to Treat the Stomach to ≥50Gy in Esophageal and GE Junction Cancer? (2019) (0)
TH‐EF‐BRD‐01: Fluence Map Optimization Using a Voxel‐Based Reduced‐Order Constrained Optimization Model (2015) (0)
Linear-Quadratic Dose Correction for Chest Wall Pain in Thoracic Stereotactic Body Radiation (2013) (0)
TU-A-BRD-01: Outcomes of Hypofractionated Treatments - Initial Results of the WGSBRT. (2014) (0)
Using gEUD to Model Volume Effects for Pneumonitis in Prospective Data From 4 Non-Small Cell Lung Cancer (NSCLC) Dose-Escalation Trials (2013) (0)
WE‐D‐T‐6E‐09: Machine Learning for the Geometry/Intensity Relationship in IMRT (2005) (0)
2132 Analysis of biopsy outcome after three-dimensional radiation therapy of prostate cancer using dose distribution variables (1999) (0)
Post-Treatment ANC is Predictive of Poorer Overall Survival and Disease-Free Survival in Esophageal Cancer Patients after Tri-Modality Therapy (2019) (0)
PET-based Assessment of Local Failure Patterns in Non-Small Cell Lung Cancer (NSCLC) Treated With Definitive Radiotherapy (2007) (0)
Exploring Associations between Immune Parameters and Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer after Chemoradiation and Durvalumab (2020) (0)
In Reply to Tsurugai et al. (2022) (0)
FP04.01 Heart Dose is a Dosimetric Predictor of Overall Survival in Patients with NSCLC Undergoing Post-Operative Radiation Therapy (2021) (0)
O-150 Intensity modulated post-operative radiation therapy for locally advanced non-small cell lung cancer (2005) (0)
160 : Elective Nodal Irradiation in the Treatment of Non-Small-Cell Lung Cancer (2006) (0)
(2021) (0)
A local and global liver function model (2016) (0)
Planning Target Volume and FDG-PET Maximum Standardized Uptake Value, But Not Dosimetric Parameters of Target Coverage, Predict for Local Recurrence After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer (2016) (0)
Spinal Cord Toxicity With High-dose, Single-fraction Spinal Stereotactic Radiosurgery (2012) (0)
Predictive Parameters of Stereotactic Body Radiation Therapy-Induced Chest Wall Pain (2013) (0)
PO-1545: Dose-volume factors predicting esophageal after SBRT for ultra-central lung tumors (2020) (0)
Are the Unsatisfactory Outcomes after Concurrent Chemo-radiotherapy for Locally Advanced Non-small Cell Lung Cancer due to a Treatment-induced Immune Suppression? (2019) (0)
A generalized total effective entrapment metric (gTEE) to quantify burden of homogeneous and heterogeneous tumors in PET imaging for enhanced clinical outcome prediction (2014) (0)
Differential Risk of Severe or Fatal Toxicity After SBRT for Central Lung Tumors According to Distance From Proximal Bronchial Tree (2015) (0)
P27.02 Associating Cardiac Plaque Accumulation With Cardiac Toxicity and Overall Survival In Locally Advanced Non-Small Cell Lung Cancer (2021) (0)
WE‐E‐BRA‐02: Methodological Issues and Key Results in the QUANTEC 2010 Review of Radiation‐Induced Normal Tissue Toxicity (2011) (0)
Reduced-Order Constrained Optimization (ROCO): Application To Head and Neck IMRT (2011) (0)

This paper list is powered by the following services:

Andrew Jackson's Academic­Influence.com Rankings

Andrew Jackson's Degrees

Why Is Andrew Jackson Influential?

Andrew Jackson's Published Works

Published Works

Andrew Jackson's AcademicInfluence.com Rankings